3-(4-Aminophenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide

In the molecule of title pyrazoline derivative, C17H18N4OS, the pyrazole ring adopts an envelope conformation with the flap atom, which bears the methoxyphenyl substituent, displaced by 0.0750 (12) Å from the plane through the other ring atoms. The two substituted benzene rings make a dihedral angle of 70.59 (6)°. The methoxy group is twisted slightly with respect to the attached benzene ring [Cmethyl—O—C—C torsion angle = −8.84 (15)°]. An intramolecular N—H⋯N hydrogen bond occurs. In the crystal, the pyrazoline molecules are linked by N—H⋯O and N—H⋯S hydrogen bonds into zigzag layers parallel to the bc plane and stacked along the a axis by π–π interactions with centroid–centroid distances of 3.4690 (7) and 3.5792 (7) Å. C—H⋯π interactions are also present.

[1]  Qing-Shan Li,et al.  Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. , 2011, Bioorganic & medicinal chemistry letters.

[2]  A. M. Glazer,et al.  A nitrogen‐gas‐stream cryostat for general X‐ray diffraction studies , 1986 .

[3]  Olga Kennard,et al.  Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds , 1987 .

[4]  Raymond E. Davis,et al.  Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .

[5]  D. Cremer,et al.  General definition of ring puckering coordinates , 1975 .

[6]  Anthony L. Spek,et al.  Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[7]  M. Bakht,et al.  Pyrazoline bearing benzimidazoles: search for anticancer agent. , 2010, European journal of medicinal chemistry.

[8]  H. Fun,et al.  3-(4-Bromophenyl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1H-pyrazole-1-carbothioamide , 2011, Acta crystallographica. Section E, Structure reports online.

[9]  M. Palkar,et al.  Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents. , 2009, European journal of medicinal chemistry.

[10]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[11]  M. Morsy,et al.  Synthesis and investigation of anti-inflammatory activity and gastric ulcerogenicity of novel nitric oxide-donating pyrazoline derivatives. , 2009, European journal of medicinal chemistry.

[12]  G. Vanangamudi,et al.  Synthesis, spectral studies and antimicrobial activities of some 2-naphthyl pyrazoline derivatives. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[13]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[14]  H. Fun,et al.  3-(4-Chlorophenyl)-5-(4-ethoxyphenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide ethanol monosolvate , 2013, Acta crystallographica. Section E, Structure reports online.

[15]  Simon P. Westrip,et al.  publCIF: software for editing, validating and formatting crystallographic information files , 2010 .

[16]  Wei-yong Liu,et al.  The synthesis, X-ray crystal structure and optical properties of novel 1,3,5-triaryl pyrazoline derivatives , 2010 .

[17]  M. Abid,et al.  Novel Pd(II) complexes of 1-N-substituted 3-phenyl-2-pyrazoline derivatives and evaluation of antiamoebic activity. , 2008, European journal of medicinal chemistry.